Literature DB >> 19915008

The cleavage of semaphorin 3C induced by ADAMTS1 promotes cell migration.

Cary Esselens1, Jordi Malapeira, Núria Colomé, Carmen Casal, Juan Carlos Rodríguez-Manzaneque, Francesc Canals, Joaquín Arribas.   

Abstract

Metastasis is a sequential process that allows cells to move from the primary tumor and grow elsewhere. Because of their ability to cleave a variety of extracellular signaling and adhesion molecules, metalloproteases have been long considered key components of the metastatic program. However, the function of certain metalloproteases, such as ADAMTS1, is not clear and seems to depend on the cellular environment and/or the stage of tumor progression. To characterize the function of ADAMTS1, we performed two alternative proteomic approaches, difference gel electrophoresis and stable isotope labeling by amino acids in cell culture, to identify novel substrates of the metalloprotease. Both techniques showed that overexpression of ADAMTS1 leads to the release of semaphorin 3C from the extracellular matrix. Although semaphorins are well known regulators of axon guidance, accumulating evidence shows that they may also participate in tumor progression. Here, we show that the cleavage of semaphorin 3C induced by ADAMTS1 promotes the migration of breast cancer cells, indicating that the co-expression of these molecules in tumors may contribute to the metastatic program.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19915008      PMCID: PMC2807303          DOI: 10.1074/jbc.M109.055129

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

Review 1.  Matrix metalloproteinases: a tail of a frog that became a prince.

Authors:  Constance E Brinckerhoff; Lynn M Matrisian
Journal:  Nat Rev Mol Cell Biol       Date:  2002-03       Impact factor: 94.444

2.  Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4.

Authors:  J D Sandy; J Westling; R D Kenagy; M L Iruela-Arispe; C Verscharen; J C Rodriguez-Mazaneque; D R Zimmermann; J M Lemire; J W Fischer; T N Wight; A W Clowes
Journal:  J Biol Chem       Date:  2001-01-26       Impact factor: 5.157

Review 3.  Protease degradomics: a new challenge for proteomics.

Authors:  Carlos López-Otín; Christopher M Overall
Journal:  Nat Rev Mol Cell Biol       Date:  2002-07       Impact factor: 94.444

Review 4.  To move or not to move? Semaphorin signalling in cell migration.

Authors:  Luca Tamagnone; Paolo M Comoglio
Journal:  EMBO Rep       Date:  2004-04       Impact factor: 8.807

5.  A proteomic view on genome-based signal peptide predictions.

Authors:  H Antelmann; H Tjalsma; B Voigt; S Ohlmeier; S Bron; J M van Dijl; M Hecker
Journal:  Genome Res       Date:  2001-09       Impact factor: 9.043

6.  Mouse macrophage metalloelastase gene transfer into a murine melanoma suppresses primary tumor growth by halting angiogenesis.

Authors:  M J Gorrin-Rivas; S Arii; M Furutani; M Mizumoto; A Mori; K Hanaki; M Maeda; H Furuyama; Y Kondo; M Imamura
Journal:  Clin Cancer Res       Date:  2000-05       Impact factor: 12.531

Review 7.  Matrix metalloproteinase inhibitors and cancer: trials and tribulations.

Authors:  Lisa M Coussens; Barbara Fingleton; Lynn M Matrisian
Journal:  Science       Date:  2002-03-29       Impact factor: 47.728

8.  Characterization of METH-1/ADAMTS1 processing reveals two distinct active forms.

Authors:  J C Rodriguez-Manzaneque; A B Milchanowski; E K Dufour; R Leduc; M L Iruela-Arispe
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

9.  Expression of METH-1 and METH-2 in pancreatic cancer.

Authors:  T Masui; R Hosotani; S Tsuji; Y Miyamoto; S Yasuda; J Ida; S Nakajima; M Kawaguchi; H Kobayashi; M Koizumi; E Toyoda; S Tulachan; S Arii; R Doi; M Imamura
Journal:  Clin Cancer Res       Date:  2001-11       Impact factor: 12.531

10.  Correlation of MDR-1, nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients.

Authors:  Eleni Galani; Joseph Sgouros; Chariklia Petropoulou; Jim Janinis; Gerassimos Aravantinos; Dionysia Dionysiou-Asteriou; Demosthenes Skarlos; Efstathios Gonos
Journal:  Anticancer Res       Date:  2002 Jul-Aug       Impact factor: 2.480

View more
  48 in total

1.  Genome-wide detection of natural selection in African Americans pre- and post-admixture.

Authors:  Wenfei Jin; Shuhua Xu; Haifeng Wang; Yongguo Yu; Yiping Shen; Bailin Wu; Li Jin
Journal:  Genome Res       Date:  2011-11-29       Impact factor: 9.043

Review 2.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

Review 3.  Navigating breast cancer: axon guidance molecules as breast cancer tumor suppressors and oncogenes.

Authors:  Gwyndolen C Harburg; Lindsay Hinck
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-08-05       Impact factor: 2.673

4.  LETR1 is a lymphatic endothelial-specific lncRNA governing cell proliferation and migration through KLF4 and SEMA3C.

Authors:  Luca Ducoli; Saumya Agrawal; Eliane Sibler; Tsukasa Kouno; Carlotta Tacconi; Chung-Chao Hon; Simone D Berger; Daniela Müllhaupt; Yuliang He; Jihye Kim; Marco D'Addio; Lothar C Dieterich; Piero Carninci; Michiel J L de Hoon; Jay W Shin; Michael Detmar
Journal:  Nat Commun       Date:  2021-02-10       Impact factor: 14.919

5.  Class 3 semaphorins induce F-actin reorganization in human dendritic cells: Role in cell migration.

Authors:  Sabrina Curreli; Bin Sheng Wong; Olga Latinovic; Konstantinos Konstantopoulos; Nicholas M Stamatos
Journal:  J Leukoc Biol       Date:  2016-07-12       Impact factor: 4.962

6.  Semaphorin 7a links nerve regeneration and inflammation in the cornea.

Authors:  Abed Namavari; Shweta Chaudhary; Okan Ozturk; Jin-Hong Chang; Lisette Yco; Snehal Sonawane; Neelima Katam; Vishakha Khanolkar; Joelle Hallak; Joy Sarkar; Sandeep Jain
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-09       Impact factor: 4.799

7.  PGF2α-F-prostanoid receptor signalling via ADAMTS1 modulates epithelial cell invasion and endothelial cell function in endometrial cancer.

Authors:  Margaret C Keightley; Kurt J Sales; Henry N Jabbour
Journal:  BMC Cancer       Date:  2010-09-14       Impact factor: 4.430

8.  The miR-181d-regulated metalloproteinase Adamts1 enzymatically impairs adipogenesis via ECM remodeling.

Authors:  S-Z Chen; L-F Ning; X Xu; W-Y Jiang; C Xing; W-P Jia; X-L Chen; Q-Q Tang; H-Y Huang
Journal:  Cell Death Differ       Date:  2016-07-22       Impact factor: 15.828

9.  The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis.

Authors:  X Lu; S J Mazur; T Lin; E Appella; Y Xu
Journal:  Oncogene       Date:  2013-06-17       Impact factor: 9.867

10.  Expression of ADAMTS1 and its correlation with angiogenesis in primary gastric cancer and lymph node metastasis.

Authors:  Jing Chen; Yu Zhi; Xiaojing Chang; Shuanglong Zhang; Dongqiu Dai
Journal:  Dig Dis Sci       Date:  2012-09-22       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.